INTRODUCTION
Undifferentiated cells that have the potential to develop into specialised cell types that carry out different functions are generally described as 'stem cells' and defined biologically according to certain criteria such as the ability to self-renew or differentiate into multiple cell types. Stem cells from an adult tissue exist either in the context of organ and tissue growth homeostasis, or to provide a source of cells for repair.
The isolation and characterisation of mesenchymal stem cells from such an accessible source as the teeth has opened up a new field of research and the possibility of finding a source of autologous or allogeneic mesenchymal stem cells that can be used in the treatment of many clinical conditions in dentistry and medicine.
Mesenchymal stem cells can be obtained with ease from dental/oral tissue, making them an attractive source of autologous stem cells. They offer a biological solution for restoring damaged dental tissues such as vital pulp engineering, regeneration of periodontal ligament lost in periodontal disease, and for generation of complete or partial tooth structures to form biological implants. Dental mesenchymal stem cells share properties with mesenchymal stem cells from bone marrow and there is a considerable potential for these cells to be used in different stem-cell-based therapies, such as bone and muscle regeneration. In addition, their immunosuppressive-immunomodulatory properties make these cells a suitable source for treating immunodisorders like systematic lupus erythematosus. In addition, gingival tissue might also be a very good source of epithelial cells used in the treatment of severe ocular surface disorders. Being such an accessible source for different stem cells, the tooth and the attached gingival tissue (usually discarded in the clinics) represent an ideal source of autologous or allogeneic stem cells that can be used in the treatment of many clinical conditions in dentistry and medicine.
repair by production of new dentine by new odontoblast-like cells, reported by Smith et al. 1 and Smith and Lesot, 2 suggests that the dental pulp may contain mesenchymal stem cells.
Stem cells from the tooth pulp and several other dental tissues have now been identified and characterised (Fig. 1) . [3] [4] [5] [6] [7] [8] [9] In 2000 Grontos and collaborators 3 first identified a population of cells isolated from the dental pulp of human third molars and termed them dental pulp stem cells (DPSCs). These cells were characterised by their high proliferation and colonyforming properties and when compared to bone marrows cells (BMSCs) in vitro, shared similar immunophenotype. These cells were shown to produce sporadic but densely calcified nodules.
3 When transplanted in vivo (using immunocompromised mice as hosts), the cells derived from dental pulp (DPSCs) generated functional dental tissue in the form of dentine/pulplike complexes. 4 Moreover, further characterisation revealed that DPSCs were capable of differentiating into adipoctyes, 4 osteoblasts and endoteliocytes.
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and this might be due to their developmental origin as neural crest derived cells.
STEM CELLS FROM HUMAN EXFOLIATED DECIDUOUS TEETH
Obtaining stem cells from human exfoliated deciduous teeth (SHED) is both simple and convenient.
In 2003 Miura and collaborators identified SHED cells as highly proliferative, clonogenic cells capable of differentiating into a variety of cell types including neural cells, adipocytes and odontoblasts. 11 After in vivo transplantation, SHED cells were found to be able to induce bone formation, generate dentine [11] [12] [13] and survive in mouse brain along with expression of neural markers.
11 When compared to DPSCs, SHED cells exhibited higher proliferation rates, increased population doublings, osteoinductive capacity in vivo and an ability to form sphere-like clusters.
11
Results from in vivo transplantation suggested that SHED have a greater capability for mineralisation than DPSCs.
14

PERIODONTAL LIGAMENT STEM CELLS
The periodontal ligament (PDL), located between the cementum and the inner wall of the alveolar bone socket, contains specialised connective tissue that provides nourishment to the teeth and regulates periodontal homeostasis. It has long been recognised to contain a population of progenitor cells. 15 In 2004, Seo et al., 16 revealed that stem cells from human periodontal ligament (PDLSCs) were capable of differentiating along multilineages to produce cementoblast-like cells and adipocytes. In this study, the PDLSCs extracted from human third molars by single colony selection were characterised as STRO-1/CD146 positive (stem cell markers). 16 Moreover, during in vivo studies cementum/PDL-like structures formed, along with dense collagen fibres similar to Sharpey's fibres showing their potential to regenerate PDL attachment, critical in the development and maintenance of a functional tooth.
When the PDL cells were co-transplanted with a different source of dental stem cells derived from the SCAP cells, a construction of root/periodontal complex was formed using a hydroxyapatite/tricalcium phosphate (HA/TCP) carrier into tooth sockets of miniature pigs. 17 The root/periodontal complex was found to be capable of supporting a porcelain crown and resulted in normal tooth function.
PDL cells maintain their tissue regeneration capacity even after recovery from frozen human tissue. 18 These results suggest the possibility of cryopreserved PDL from extracted teeth being utilised for future therapeutic purposes.
ROOT APICAL PAPILLA STEM CELLS
As mentioned in the Introduction, the third molars are the most commonly extracted teeth and very often still not completed their root development, the cells located in the apical papilla (root foramen area) represent another unique population of dental stem cells -SCAP cells.
These cells have the capacity to differentiate into odontoblasts and adipocytes. They have shown a higher proliferative potential compared with DPSCs when measured by bromodeoxyuridine (BrdU) uptake.
17
SCAP appear to be a source of primary odontoblasts responsible for the formation of root dentine, 17 whereas DPSCs are possibly the source of replacement odontoblasts that produce reparative dentine. 3 
DENTAL FOLLICLE STEM CELLS
The dental follicle is a loose connective tissue sac surrounding the enamel organ and the dental papilla of the developing tooth germ before eruption.
19 Cells isolated from the follicular sacs of human third molars were characterised by their rapid attachment in culture and expression of putative stem cell markers Nestin and Notch-1.
20
Their ability to differentiate into cementoblasts was shown in a study using bovine dental follicle cells (BDFCs) that were transplanted in vivo into immunocompromised-SCID mice.
21,22
Dental follicle stem cells (DFSCs) can give rise to three major cell types in periodontium: cementoblasts, osteoblasts, and fibroblasts. A recent study from Bay et al. showed that coculture of DFC with Hertwig epithelial root sheath cells in vitro enhances the ability of these cells to regenerate cementum and periodontal ligament after transplantation.
23
GINGIVA AS A SOURCE OF STEM CELLS
Gingival tissue is one of the important parts of the periodontium, showing remarkable wound healing and regenerative capacity. Gingival fibroblasts are a heterogeneous cell population that play a crucial part in the process of wound healing. They respond differently to growth factors and produce specific extracellular matrix proteins during the healing process.
24-28
Progenitor cells and multipotent MSC subpopulation of cells have been isolated 
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and characterised from gingival fibroblasts. [29] [30] [31] [32] These fibroblasts are easily accessible and recently have been used to derive induced pluripotent stem cell lines (IPS).
33
ORAL EPITHELIUM
Another very interesting source of stem cells is epithelial cells from the oral epithelium. In 2003 Nakamura and collaborators successfully cultured and transplanted rabbit oral mucosal epithelial cells on amniotic membranes. 34 In 2004 transplantation of cultivated autologous oral mucosal epithelial cells in patients with severe ocular surface disorders was reported.
35
A more recent study has shown the expression of angiogenesis-related factors in human corneas after cultivated oral mucosal epithelial transplantation (COMET), suggesting that the expression of FGF-2, VEGF, PEDF, endostatin, and IL-1ra is similar in normal corneas, conjunctiva, oral mucosa, and corneas after COMET.
36 A long-term study has shown the results of this technique and suggested it is a very successful way of treatment for severe ocular surface disorders.
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CLINICAL APPLICATIONS OF DENTAL STEM CELLS
Repairing/regenerating dental tissues
The tooth is a complex organ comprising three specialised hard tissues: enamel, dentine and cementum encapsulating the dental pulp and anchored by the periodontal ligament in the alveolar socket of the jaw.
Once damaged, tooth enamel is not capable of self-repairing, while dentine and cementum show limited capacity of regeneration. Studies have revealed that extracellular matrix derivatives and breakdown products from dental pulp and dentine influence pulp cell migration. Recruited cells exhibited increased stem cell marker expression indicating that dental ECMs and their breakdown products selectively attract progenitor cells that contribute to repair processes.
38,39
When a tooth is damaged, but still reparable, regeneration of the remaining dental structure can prevent or delay the loss of the whole tooth. When the dental pulp is infected and diagnosed with irreversible pulpitis, regardless of the amount of remaining normal pulp tissue, there is no treatment that can reverse the clinical situation and the entire pulp has to be removed, followed by root canal treatment, disinfecting the pulp space and replacing it with inorganic materials.
The regeneration of the dental pulp and creation of dental pulp that is vital, functionally competent, and able to form and repair dentine has been a long-time quest.
De novo regeneration of dental pulp
The dental pulp has an interesting anatomical location being encased in a mineralised chamber that in many ways resembles bone marrow.
Blood and nerve supply to tooth pulp is, however, restricted by entry through the root tips.
In 2008 Cordeiro and collaborators 40 suggested the SHED cells may be a valuable cell source for dental pulp tissue engineering. They seeded SHED cells in biodegradable scaffolds prepared within human tooth slices and transplanted into immunodeficient mice. The resulting tissue presented an architecture and cellularity that resembled those of a physiologic dental pulp. Ultrastructural analysis with transmission electron microscopy and immunohistochemistry for dentine sialoprotein suggested that SHED differentiated into odontoblast-like cells in vivo. 40 Huang et al. 41 used DPSCs and SCAP cells isolated from human third molars to demonstrate de novo regeneration of dental pulp in empty root canal spaces. These cells were seeded onto poly-D,L-lactide/ glycolide scaffold and inserted into the canal space of root fragments followed by subcutaneous transplantation into immunocompromised-SCID mice. After three to four months a histological analysis on the tooth fragments showed that the root canal space was filled with pulp-like tissue with well-established vascularisation. Moreover, a continuous layer of mineralised tissue resembling dentine was deposited on the existing dentinal walls of the canal. This dentine-like structure appeared to be produced by a newly formed layer of odontoblast-like cells.
41
Periodontal regeneration
A big challenge in dentistry is the regeneration/repair of the periodontal ligament, particularly since periodontitis is an inflammatory disease with high prevalence, resulting in irreversible loss of connective tissue attachment, supporting alveolar bone and consequent tooth loss. The periodontium is a specialised tissue complex that surrounds and supports the teeth in the alveolar bone.
An area that holds some promise is the use of dental stem cells to replicate the key events in periodontal development both temporally and spatially so that healing can occur in a sequential manner in order to regenerate the periodontium. 42 An alternative approach to conventional periodontal regeneration methods was employed by Hasegawa et al. 43 involving engineered cell sheets to facilitate human periodontal ligament (HPDL) cell transplantation. Periodontal ligament cells isolated from a human third molar tooth were cultured on poly (N-isopropylacryl-amide) (PIPAAm) dishes that induce spontaneous detachment as viable cell sheets upon low temperature treatment. Athymic rats that had periodontium and cementum removed from their first molars were used to determine the potential of HPDL cell sheets to regenerate periodontal tissues. Fibril anchoring resembling native periodontal ligament fibres together with an acellular cementum-like layer was observed indicating that this technique could be applicable to future periodontal regeneration using dental stem cells.
43
In a recent study Tsumanuma et al. 44 compared the effects of PDLSC, alveolar periosteum cells, and BMDSCs combined with β-TCP/collagen scaffold transplanted into the bone defect. After eight weeks of transplantation there was a formation of cementum and periodontal ligament fibres. However, the highest alveolar bone regeneration, as well as nerve formation, was observed with PDLSCs.
PDL cells were shown to be capable of forming periodontal tissue around the titanium implants in rats. The potential of these cells to organise the periodontal tissue after tooth loss might open the possibility for new therapeutic approaches in implant therapy and offer an alternative to osseointegrated dental implants.
45
In all these approaches, the question remains concerning the extent any reconstituted periodontium can maintain integrity and function over long periods of time, and there is an obvious need GENERAL for translational and long-term studies. However, current treatments for severe periodontitis are limited and new dental stem cell-based treatments are likely to be the subject of intensive clinical research.
Bone repair
Dental pulp cells are a promising source of MSCs for use in craniomaxillofacial repair and regeneration since they express the osteogenic markers and respond to some growth factors for bone differentiation as osteoblasts. SHED cells transplanted together with hydroxyapatite/tricalcium phosphate into calvarial defects in mice were capable of completely repairing the defect after six months.
46
A clinical study revealed that when a collagen sponge scaffold with dental pulp stem/progenitor cells (DPCs) is transplanted into the mandible, oro-maxillofacial (OMF) bone tissue repair with a good vascularisation and lamellar architecture was achieved after one year of the engraftment. 47 An important consideration is that dental pulp mesenchymal stem cells are derived from neural crest cells, the same cells from which craniofacial osteoblasts are derived.
Muscle regeneration
The potential of human dental pulp stem cells in muscle regeneration was shown when SHED cells were injected into dogs suffering from muscular dystrophy. Analysis of the DPSCs ability for migration, engraftment, myogenic potential and expression of human dystrophin in affected muscles revealed the formation of chimeric canine/ human muscle fibres. A better clinical condition was also observed in the dog, which received monthly arterial injections of SHED cells.
48 A recent study done by Martinez and his colleagues 49 investigated the potential of PDL cells to support the heart valve cell lineage, specifically the concomitant differentiation to both endothelial cell (EC) and smooth muscle cell (SMC) types, suggesting that PDL cells cultured under steady flow environments can be used in heart valve tissue engineering.
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IMMUNOSUPPRESSIVE-IMMUNOMODULATORY PROPER-TIES OF DENTAL STEM CELLS
Mesenchymal stem cells have been shown to have immuno-modulatory and regulatory effects on T-and B-lymphocytes, dendritic cells and natural killer cells.
50-55
These cells do not express MHC class II antigens on their surface when expanded in culture, indicating a possible usage of the mesenchymal stem cells as allogeneic source in treating diseases like graft-versus-host disease (GVHD).
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The dental stem cells are an easily accessible source of mesenchymal stem cells and in 2009 Wada and colleagues showed the immunosuppressive properties of PDL, DP and gingival fibroblast (GF) cells, indicating that these properties might be mediated by soluble factors, produced by activated PBMSC.
57 Just one year later, Yamaza et al. showed that SHED cells possess immunomodulatory properties and suggested these cells are an accessible and feasible mesenchymal stem cell source for treating immunodisorders like systematic lupus erythematosus (SLE).
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WHOLE TOOTH GENERATION
Functional teeth can be experimentally bioengineered in mice by re-association of dissociated tooth germ cells. [59] [60] [61] [62] The re-aggreation produces multiple, small 'toothlets' whose shape bears no resemblance to the shape of the scaffold used (Fig. 2) . In this case the role of the scaffold is merely to hold the cells together in a 3D environment. Epithelial and mesenchymal cells are expanded in culture to generate sufficient cells. The two cell populations are combined in vitro bringing the epithelial and mesenchymal cells into direct contact. Interaction between these cell types leads to formation of an early stage tooth primordium. The tooth primordium is surgically transplanted into the mouth and left to develop into a whole bioengineered tooth.
The cells used in these experiments were from embryonic tooth germs and a large number of cells were required to make a tooth. Obviously, this is a problem when trying to translate into the clinic. Thus a major unsolved challenge that we are facing today in the attempts of bioengineering a whole tooth is identifying non-embryonic sources of cells that have tooth-forming abilities following in vitro expansion.
The ability of non-dental cell sources to respond to odontogenic signals following in vitro expansion was demonstrated when it was shown that cultured adult bone marrow stromal cells could form teeth when combined with inductive embryonic oral epithelium. 63 In a very recent publication we have shown that epithelial cells derived from adult human gingival tissue are capable of responding to tooth-inducing signals from embryonic mouse tooth mesenchyme, and hybrid teeth with crown and root formation were formed.
64
One simple issue that has emerged from using recombination experiments of only human embryonic tooth cells in our lab at King's College is that human bioengineered tooth development follows its own biological clock of development and it takes much longer than when mouse cells are used (unpublished). Thus, whereas 
